Table 4 The diagnostic utility of predictors for cervical cancer (univariate analysis)
From: MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer
OR | 95% CI | P value | |
|---|---|---|---|
Ages | |||
< 30 years | 1 | ||
31–40 years | 1.4 | 0.4–5.1 | 0.580 |
41–50 years | 1.7 | 0.4–6.5 | 0.442 |
51–60 years | 3.5 | 0.8–16.4 | 0.109 |
> 60 years | 35.2 | 3.6–344.2 | 0.002 |
HPV E6/E7 | |||
negative | 1 | ||
positive | 244.4 | 13.6–4376.4 | <0.0001 |
miR-9 | |||
negative | 1 | ||
positive | 8.2 | 3.3–20.3 | <0.0001 |
miR-21 | |||
negative | 1.0 | ||
positive | 12.3 | 4.8–31.7 | <0.0001 |
miR-155 | |||
negative | 1.0 | ||
positive | 41.7 | 9.1–191.2 | <0.0001 |